Hemolytic Uremic Syndrome Incidence in New York

Emerging Infectious Diseases

Volumn 10, Issue 5, 2004, Pages 928-931

  Chang, Hwa Gan H ^a   Tserenpuntsag, Boldtsetseg ^b   Kacica, Marilyn ^a,b   Smith, Perry F ^a,b   Morse, Dale L ^a,b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; ADULT; ANTIMICROBIAL THERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; DIARRHEA; FEMALE; HEMOLYTIC UREMIC SYNDROME; HOSPITAL DISCHARGE; HUMAN; INCIDENCE; LENGTH OF STAY; LEUKOCYTE COUNT; MALE; RISK FACTOR; UNITED STATES;

EID: 2142658798     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1005.030456     Document Type: Conference Paper

References (17)

1. Gianviti A, Rosmini F, Caprioli A. Hemolytic uremic syndrome in childhood: surveillance and case control studies in Italy. Italian HUS Study Group. Pediatr Nephrol 1994;8:705-9.
2. Martin D, MacDonald K, White K, Soler J, Osterholm M. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota. N Engl J Med 1990;323:1161-7.
3. Siegler RL, Pavia AT, Liansen FL, Christofferson RD, Cook JB. Atypical hemolytic-uremic syndrome: a comparison with post-diarrheal disease. J Pediatr 1996;128:505-11.
4. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25.
5. Boyce TG, Swerdlow DL, Griffin PM. Escherichia coli O157:H7 and the hemolytic-uremic syndrome. N Engl J Med 1995;333:364-8.
6. Tarr PI, Neill MA, Clausen CR, Watkins SL, Christie DL, Hickman RO. E. coli O157:H7 and the hemolytic uremic syndrome: importance of early cultures in establishing the etiology. J Infect Dis 1990;162:553-6.
7. Ikeda K, Ida O, Kimoto K, Takatorige T, Nakanishi N, Tatara K. Predictors for the development of haemolytic uremic syndrome with Escherichia coli O157:H7 infections: with focus on the day of illness. Epidemiol Infect 2000;124:343-9.
8. Wong CS, Jelacic S, Habeeb RL, Watkins SL, Tarr PI. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157: H7 infections. N Engl J Med 2000;342:1930-6.
9. Bell BP, Griffin PM, Lozano P, Christie DL, Kobayashi JM, Tarr PI. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections. Pediatrics 1997;100:e12.
10. Cimolai N, Carter JE, Morrison BJ, Anderson JD. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome. J Pediatr 1990;116:589-92.
11. Cimolai N, Basalyga S, Mah DG. A continuing assessment of risk factors for the development of Escherichia coli O157:H7-associated hemolytic uremic syndrome. Clin Nephrol 1994;42:85-9.
12. Centers for Disease Control and Prevention. Case definitions for infectious conditions under public health surveillance. MMWR Morb Mortal Wkly Rep 1997;46:1-57.
13. International Working Group for Disease Monitoring and Forecasting. Capture-recapture and multi-record systems estimation. 1: History and theoretical development. Am J Epidemiol 1995;142:1047-58.
14. Cummings KC, Mohle-Boetani JC, Werner SB, Vugia DJ. Population-based trends in pediatric hemolytic uremic syndrome in California, 1994-1999: substantial underreporting and public health implications. Am J Epidemiol 2002;155:941-8.
15. Decludt B, Bouvet P, Mariani-Kurkdjian P, Grimont F, Grimont P, Hubert A, et al. Haemolytic uraemic syndrome and Shiga toxin-producing Escherichia coli infection in children in France. Epidemiol Infect 2000;124:215-20.
16. Griffin PM, Olmstead LC, Petras RE. Escherichia coli O157:H7 associated colitis: a clinical and histological study of 11 cases. Gastroenterology 1990;99:142-9.
17. Besser RE, Griffin PM, Slutsher L. Escherichia coli O157:H7 gastroenteritis and hemolytic uremic syndrome: an emerging infectious disease. Annu Rev Med 1999;50:355-67.